Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Oct 13;13:10315–10322. doi: 10.2147/OTT.S255586

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Wang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Delicaflavone united with DDP regulated lung cancer DDP resistant cells invasion, migration. (A–D) Wound healing showed the migration ability of the Delicaflavone united with DDP group was significantly reduced than that of the Delicaflavone alone group or DDP alone group. (E–H) Transwell assay showed the migration number of cell were decreased was significantly reduced in the Delicaflavone united with DDP group. (I–L) In vitro tumor Xenografts, the results of tumor volume was reduced in the Delicaflavone united with DDP group. Data represent mean ± SD. *P < 0.05. ^#P < 0.05 represents compared with the Delicaflavone alone group or DDP alone group.